Omnipod: Current Podders correction resources | Source Library

Clinical resourceProfessional clinical guidance

Source type: Clinical resource
Access type: Publisher
Publisher: Insulet / Omnipod
Date: 2026
Added: 2026-07-05

Trust profile

VV Source Trust Matrix v1.0

VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.

Professional clinical guidance

Publisher type: Professional guidance
Bias profile: Moderate

This source is strongest for safety and consumer context and weaker for mechanism and trial discovery.

VV Source Fit Score 1.0

Fit by use case

Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.

Frameworks ->

Regulatory status: 63/100; Context Source
Clinical outcomes: 78/100; Strong Support
Mechanism: 63/100; Context Source
Safety: 86/100; Strong Support
Consumer context: 82/100; Strong Support
Trial discovery: 63/100; Context Source

Best used for

Clinical context
Practice guidance

Weak for

Replacing primary evidence

Used in Viral Vitalism

Supporting evidencebrief1 reference

FDA Flagged a Serious Omnipod Insulin-Delivery Recall

Roles: Supporting evidence

Show section-level references

FDA classified Insulet's removal of certain Omnipod Pods from affected lots as a Class I recall because a cannula tear may cause insulin leakage and under-delivery.

Related studies

No structured study record is currently attached to this source.

Related sources

GovernmentU.S. health regulator